Possible role of catheters in Saccharomyces boulardii fungemia

被引:159
作者
Hennequin, C [1 ]
Kauffmann-Lacroix, C
Jobert, A
Viard, JP
Ricour, C
Jacquemin, JL
Berche, P
机构
[1] CHU Amiens, Serv Parasitol Mycol & Med Trop Prof C Raccurt, F-80054 Amiens 1, France
[2] Hop Necker Enfants Malad, Microbiol Serv, F-75015 Paris, France
[3] Hop Necker Enfants Malad, Serv Reanimat Digest, F-75015 Paris, France
[4] Hop Necker Enfants Malad, Serv Immunol Clin, F-75015 Paris, France
[5] CHU La Miletrie, Lab Parasitol & Mycol Med, F-86021 Poitiers, France
关键词
D O I
10.1007/s100960050003
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Four cases of Saccharomyces boulardii fungemia, a very rare side effect of Saccharomyces boulardii therapy, are reported. The clinical impact of Saccharomyces boulardii infection appeared to be moderate. However, even though organ involvement was never demonstrated. septic shock with no other etiology was observed in one of our patients. All patients had an indwelling vascular catheter. Contamination of the air, environmental surfaces, and hands following the opening of a packet suggests that catheter contamination may have been a source of infection. To prevent catheter contamination it is recommended that packets or capsules of Saccharomyces boulardii be opened with gloves, outside the patient's room.
引用
收藏
页码:16 / 20
页数:5
相关论文
共 20 条
  • [1] Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii
    Bassetti, S
    Frei, R
    Zimmerli, W
    [J]. AMERICAN JOURNAL OF MEDICINE, 1998, 105 (01) : 71 - 72
  • [2] DISPOSITION KINETICS OF SACCHAROMYCES-BOULARDII IN MAN AND RAT
    BLEHAUT, H
    MASSOT, J
    ELMER, GW
    LEVY, RH
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 1989, 10 (04) : 353 - 364
  • [3] Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients - A multicenter, randomized, double-blind placebo-controlled trial
    Bleichner, G
    Blehaut, H
    Mentec, H
    Moyse, D
    [J]. INTENSIVE CARE MEDICINE, 1997, 23 (05) : 517 - 523
  • [4] BOUCAUD C, 1996, REANIMATION URGENCES, V5, P665
  • [5] SACCHAROMYCES-CEREVISIAE FUNGEMIA - CASE-REPORT AND REVIEW OF THE LITERATURE
    CIMOLAI, N
    GILL, MJ
    CHURCH, D
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1987, 8 (02) : 113 - 117
  • [6] Saccharomyces boulardii fungemia in a patient receiving ultra-levure therapy
    Fredenucci, I
    Chomarat, M
    Boucaud, C
    Flandrois, JP
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 27 (01) : 222 - 223
  • [7] Epidemiology of nosocomial fungal infections
    Fridkin, SK
    Jarvis, WR
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (04) : 499 - &
  • [8] RAPID CHARACTERIZATION OF 4 SPECIES OF THE SACCHAROMYCES SENSU-STRICTO COMPLEX ACCORDING TO MITOCHONDRIAL-DNA PATTERNS
    GUILLAMON, JM
    BARRIO, E
    HUERTA, T
    QUEROL, A
    [J]. INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY, 1994, 44 (04): : 708 - 714
  • [9] NEW AND EMERGING YEAST PATHOGENS
    HAZEN, KC
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1995, 8 (04) : 462 - &
  • [10] Fungemia in cancer patients undergoing chemotherapy versus surgery: Risk factors, etiology and outcome
    Kralovicova, K
    Spanik, S
    Oravcova, E
    Mrazova, M
    Morova, E
    Gulikova, V
    Kukuckova, E
    Koren, P
    Pichna, P
    Nogova, J
    Kunova, A
    Trupl, J
    Krcmery, V
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1997, 29 (03) : 301 - 304